Oxford, MA, United States of America

Yuri Iozzo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sanofi. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yuri Iozzo in Protein-Protein Interaction Sensing

Introduction

Yuri Iozzo is an accomplished inventor based in Oxford, MA (US). He has made significant contributions to the field of protein-protein interaction sensing. His innovative work has led to the development of a patented technology that enhances our understanding of complex biological interactions.

Latest Patents

Yuri Iozzo holds a patent for a method titled "Sensing of protein-protein interaction." This patent describes a composite image that includes multiple complex images of samples containing a protein-protein complex. The method involves masking the composite image to create distinct portions, accessing three-dimensional shapes of the involved proteins, and utilizing docking models to generate fitment scores. This process ultimately allows for the selection of a model that best represents the protein-protein complex based on the calculated scores. He has 1 patent to his name.

Career Highlights

Yuri Iozzo is currently employed at Sanofi, a global biopharmaceutical company. His work at Sanofi focuses on advancing research in protein interactions, which is crucial for drug development and therapeutic applications. His expertise in this area has positioned him as a valuable asset to his team.

Collaborations

Yuri collaborates with notable colleagues, including Yanfeng Zhou and Yu Qiu. Their combined efforts contribute to the advancement of research in the field of protein interactions.

Conclusion

Yuri Iozzo's innovative work in protein-protein interaction sensing exemplifies the impact of scientific research on biopharmaceutical advancements. His contributions continue to shape the future of drug development and therapeutic strategies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…